Femme et Homme
- | Pays :
- Spain
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine the safety and tolerability of VCN-01 either administered alone or in combination with Abraxane®/Gemcitabine, and to determine the recommended phase II dose of VCN-01 alone or in combination with Abraxane®/Gemcitabine.
Critère d'inclusion
- Locally Advanced Solid Tumors ,Metastatic Solid Tumors ,PANCREATIC ADENOCARCINOMA'